Glutamate is effective in decreasing opacity formed in galactose-induced cataract model

被引:0
作者
Masaru Takashima
Shunki Yamamura
Chie Tamiya
Mayumi Inami
Yoshihiro Takamura
Masaru Inatani
Masaya Oki
机构
[1] University of Fukui,Department of Industrial Creation Engineering, Graduate School of Engineering
[2] University of Fukui,Technical Division, School of Engineering
[3] University of Fukui,Department of Ophthalmology, Faculty of Medical Sciences
[4] University of Fukui,Life Science Innovation Center
来源
Scientific Reports | / 14卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Although cataract is the leading cause of blindness worldwide, the detailed pathogenesis of cataract remains unclear, and clinically useful drug treatments are still lacking. In this study, we examined the effects of glutamate using an ex vivo model in which rat lens is cultured in a galactose-containing medium to induce opacity formation. After inducing lens opacity formation in galactose medium, glutamate was added, and the opacity decreased when the culture was continued. Next, microarray analysis was performed using samples in which the opacity was reduced by glutamate, and genes whose expression increased with galactose culture and decreased with the addition of glutamate were extracted. Subsequently, STRING analysis was performed on a group of genes that showed variation as a result of quantitative measurement of gene expression by RT-qPCR. The results suggest that apoptosis, oxidative stress, endoplasmic reticulum (ER) stress, cell proliferation, epithelial-mesenchymal transition (EMT), cytoskeleton, and histones are involved in the formation and reduction of opacity. Therefore, glutamate may reduce opacity by inhibiting oxidative stress and its downstream functions, and by regulating the cytoskeleton and cell proliferation.
引用
收藏
相关论文
共 181 条
  • [1] Asbell PA(2005)Age-related cataract Lancet 365 599-609
  • [2] Kohnen T(2009)Cataract surgery with implantation of an artificial lens Dtsch. Arztebl. Int. 106 695-702
  • [3] Baumeister M(2014)Etiopathogenesis of cataract: An appraisal Indian J. Ophthalmol. 62 103-110
  • [4] Kook D(1995)Older-onset diabetes and lens opacities. The Beaver dam eye study Ophthalm. Epidemiol. 2 49-55
  • [5] Klaproth OK(1990)Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the Global Burden of Disease Study 2021 Lancet 402 203-234
  • [6] Ohrloff C(1993)The lens in diabetes Eye (Lond.) 7 260-275
  • [7] Gupta VB(2014)Evaluation of neonatal streptozotocin induced diabetic rat model for the development of cataract Oxid. Med. Cell Longev 2014 463264-374
  • [8] Rajagopala M(1994)Dose-response characteristics of galactose-induced cataract in the rat Ophthalm. Res. 26 368-140
  • [9] Ravishankar B(2021)Diabetic cataract in the Nile grass rat: A longitudinal phenotypic study of pathology formation Faseb J. 35 e21593-640
  • [10] Klein BE(2004)Pharmacological prevention of diabetic cataract J. Diabetes Comp. 18 129-583